These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 31647676)

  • 21. Oligo(Lactic Acid)
    Tam YT; Repp L; Ma ZX; Feltenberger JB; Kwon GS
    Pharm Res; 2019 Mar; 36(5):70. PubMed ID: 30888509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic modelling of pentoxifylline and lisofylline after oral and intravenous administration in mice.
    Wyska E; Szymura-Oleksiak J; Pekala E; Obruśnik A
    J Pharm Pharmacol; 2007 Apr; 59(4):495-501. PubMed ID: 17430632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Poly(ethylene glycol)-block-poly(d,l-lactic acid) micelles containing oligo(lactic acid)
    Tam YT; Shin DH; Chen KE; Kwon GS
    J Control Release; 2019 Mar; 298():186-193. PubMed ID: 30790593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lisofylline suppresses ex vivo release by murine spleen cells of hematopoietic inhibitors induced by cancer chemotherapeutic agents.
    de Vries P; Singer JW
    Exp Hematol; 2000 Aug; 28(8):916-23. PubMed ID: 10989192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective randomized trial of lisofylline for the prevention of toxicities of high-dose interleukin 2 therapy in advanced renal cancer and malignant melanoma.
    Margolin K; Atkins M; Sparano J; Sosman J; Weiss G; Lotze M; Doroshow J; Mier J; O'Boyle K; Fisher R; Campbell E; Rubin J; Federighi D; Bursten S
    Clin Cancer Res; 1997 Apr; 3(4):565-72. PubMed ID: 9815721
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
    Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
    Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Chain Length and Degree of Unsaturation of Fatty Acids in the Physicochemical and Pharmacological Behavior of Drug-Fatty Acid Conjugates in Diabetes.
    Singh AK; Italiya KS; Narisepalli S; Chitkara D; Mittal A
    J Med Chem; 2021 Oct; 64(19):14217-14229. PubMed ID: 34581574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of post-treatment with lisofylline, a phosphatidic acid generation inhibitor, on sepsis-induced acute lung injury in pigs.
    Hasegawa N; Oka Y; Nakayama M; Berry GJ; Bursten S; Rice G; Raffin TA
    Am J Respir Crit Care Med; 1997 Mar; 155(3):928-36. PubMed ID: 9117028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic-pharmacodynamic modeling of methylxanthine derivatives in mice challenged with high-dose lipopolysaccharide.
    Wyska E
    Pharmacology; 2010; 85(5):264-71. PubMed ID: 20389149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lisofylline, a novel antiinflammatory compound, protects mesangial cells from hyperglycemia- and angiotensin II-mediated extracellular matrix deposition.
    Bolick DT; Hatley ME; Srinivasan S; Hedrick CC; Nadler JL
    Endocrinology; 2003 Dec; 144(12):5227-31. PubMed ID: 12960000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Co-delivery of siAlox15 and sunitinib for reversing the new-onset of type 1 diabetes in non-obese diabetic mice.
    Peng Y; Wen D; Lin F; Mahato RI
    J Control Release; 2018 Dec; 292():1-12. PubMed ID: 30393183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effect of pentoxifylline and lisofylline on deformability and aggregation of red blood cells from healthy subjects and patients with chronic venous disease.
    Słoczyńska K; Kózka M; Pękala E; Marchewka A; Marona H
    Acta Biochim Pol; 2013; 60(1):129-35. PubMed ID: 23520579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A randomized placebo-controlled trial of lisofylline in HLA-identical, sibling-donor, allogeneic bone marrow transplant recipients. The Lisofylline Marrow Transplant Study Group.
    List AF; Maziarz R; Stiff P; Jansen J; Liesveld J; Andrews F; Schuster M; Wolff S; Litzow M; Karanes C; Dahlberg S; Kirkhart B; Bianco JA; Singer JW
    Bone Marrow Transplant; 2000 Feb; 25(3):283-91. PubMed ID: 10673700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral histone deacetylase inhibitor synergises with T cell targeted immunotherapy to preserve beta cell metabolic function and induce stable remission of new-onset autoimmune diabetes in NOD mice.
    Besançon A; Goncalves T; Valette F; Dahllöf MS; Mandrup-Poulsen T; Chatenoud L; You S
    Diabetologia; 2018 Feb; 61(2):389-398. PubMed ID: 29030662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of lisofylline and pentoxifylline on the bacterial-stimulated production of TNF-alpha, IL-1 beta IL-10 by human leucocytes.
    van Furth AM; Verhard-Seijmonsbergen EM; van Furth R; Langermans JA
    Immunology; 1997 Jun; 91(2):193-6. PubMed ID: 9227316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Curcumin Delivery by Poly(Lactide)-Based Co-Polymeric Micelles: An In Vitro Anticancer Study.
    Kumari P; Swami MO; Nadipalli SK; Myneni S; Ghosh B; Biswas S
    Pharm Res; 2016 Apr; 33(4):826-41. PubMed ID: 26597940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lisofylline ameliorates intestinal and hepatic injury induced by hemorrhage and resuscitation in rats.
    Wattanasirichaigoon S; Menconi MJ; Fink MP
    Crit Care Med; 2000 May; 28(5):1540-9. PubMed ID: 10834709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lisofylline ameliorates intestinal mucosal barrier dysfunction caused by ischemia and ischemia/reperfusion.
    Wattanasirichaigoon S; Menconi MJ; Delude RL; Fink MP
    Shock; 1999 Apr; 11(4):269-75. PubMed ID: 10220304
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enantioselective reduction of pentoxifylline to lisofylline using whole-cell Lactobacillus kefiri biotransformation.
    Pekala E; Godawska-Matysik A; Zelaszczyk D
    Biotechnol J; 2007 Apr; 2(4):492-6. PubMed ID: 17285680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel diblock of copolymer of (monomethoxy poly [ethylene glycol]-oleate) with a small hydrophobic fraction to make stable micelles/polymersomes for curcumin delivery to cancer cells.
    Erfani-Moghadam V; Nomani A; Zamani M; Yazdani Y; Najafi F; Sadeghizadeh M
    Int J Nanomedicine; 2014; 9():5541-54. PubMed ID: 25489242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.